{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:10:28Z","timestamp":1763388628167,"version":"3.45.0"},"reference-count":43,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.25122\/jml-2025-0131","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:05:33Z","timestamp":1763388333000},"page":"878-885","source":"Crossref","is-referenced-by-count":0,"title":["Staging discordance in apparent early-stage ovarian neoplasms: prevalence, prognosis, and practical risk stratification"],"prefix":"10.25122","volume":"18","author":[{"given":"Mohamed Abdelwanis Mohamed","family":"Abdelaziz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Gynecological Oncology, Nottingham University Hospitals NHS Trust, City Campus, Nottingham, United Kingdom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambreen","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Gynecology and Obstetrics, Nottingham University Hospitals NHS Trust, City Campus, Nottingham, United Kingdom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasrina","family":"Akter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Gynecology and Obstetrics, Nottingham University Hospitals NHS Trust, City Campus, Nottingham, United Kingdom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddesh","family":"Prabhulingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Gynecology and Obstetrics, Nottingham University Hospitals NHS Trust, City Campus, Nottingham, United Kingdom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesma","family":"Hesham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Gynecology and Obstetrics, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, United Kingdom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustafa","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Gynecology and Obstetrics, Nottingham University Hospitals NHS Trust, City Campus, Nottingham, United Kingdom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Gynecology and Obstetrics, Nottingham University Hospitals NHS Trust, City Campus, Nottingham, United Kingdom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","reference":[{"issue":"12","key":"ref1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1634\/theoncologist.2012-0139","article-title":"Diagnosis, treatment, and follow-up of borderline ovarian tumours","volume":"17","author":"Fischerova D, Zikan M, Dundr P, Cibula D","year":"2012","unstructured":"1. Fischerova D, Zikan M, Dundr P, Cibula D, Diagnosis, treatment, and follow-up of borderline ovarian tumours, Oncologist, 2012;17(12):1515-33","journal-title":"Oncologist"},{"issue":"7","key":"ref2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1586\/era.10.90","article-title":"Clinical management of borderline ovarian tumors","volume":"10","author":"Trillsch F, Mahner S, Ruetzel J, Harter P, Ewald-Riegler N, Jaenicke F","year":"2010","unstructured":"2. Trillsch F, Mahner S, Ruetzel J, Harter P, Ewald-Riegler N, Jaenicke F, Clinical management of borderline ovarian tumors, Expert Rev Anticancer Ther, 2010;10(7):1115-24","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"ref3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease\u2020","volume":"30","author":"Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG McNeish, ESMO-ESGO Ovarian Cancer Consensus Conference Working Group","year":"2019","unstructured":"3. Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG McNeish, ESMO-ESGO Ovarian Cancer Consensus Conference Working Group, ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease\u2020, Ann Oncol, 2019;30(5):672-705","journal-title":"Ann Oncol"},{"issue":"10","key":"ref4","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1200\/JCO.2001.19.10.2658","article-title":"Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study","volume":"19","author":"Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C","year":"2001","unstructured":"4. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C, Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study, J Clin Oncol, 2001;19(10):2658-64","journal-title":"J Clin Oncol"},{"issue":"5","key":"ref5","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ","year":"2002","unstructured":"5. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ, Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis, J Clin Oncol, 2002;20(5):1248-59","journal-title":"J Clin Oncol"},{"issue":"10","key":"ref6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote I, Trop\u00e9 CG, Amant F, Kristensen GB, Ehlen T, Johnson N, European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group","year":"2010","unstructured":"6. Vergote I, Trop\u00e9 CG, Amant F, Kristensen GB, Ehlen T, Johnson N, European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group, Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer, N Engl J Med, 2010;363(10):943-53","journal-title":"N Engl J Med"},{"issue":"4","key":"ref7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis","volume":"186","author":"Kurman RJ, Shih IeM","year":"2016","unstructured":"7. Kurman RJ, Shih IeM, The dualistic model of ovarian carcinogenesis, Am J Pathol, 2016;186(4):733-47","journal-title":"Am J Pathol"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up","volume":"29","author":"Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR","year":"2005","unstructured":"8. Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR, Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up, Am J Surg Pathol, 2005;29(6):707-23","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"ref9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ygyno.2010.11.016","article-title":"Risk factors for recurrence of ovarian borderline tumors","volume":"120","author":"Shih KK, Zhou Q, Huh J, Morgan JC, Iasonos A, Aghajanian C","year":"2011","unstructured":"9. Shih KK, Zhou Q, Huh J, Morgan JC, Iasonos A, Aghajanian C, Risk factors for recurrence of ovarian borderline tumors, Gynecol Oncol, 2011;120(3):480-4","journal-title":"Gynecol Oncol"},{"issue":"5","key":"ref10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/hp.2000.8048","article-title":"Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators","volume":"31","author":"Seidman JD, Kurman RJ","year":"2000","unstructured":"10. Seidman JD, Kurman RJ, Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators, Hum Pathol, 2000;31(5):539-57","journal-title":"Hum Pathol"},{"issue":"10","key":"ref11","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG","year":"1990","unstructured":"11. Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG, A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer, Br J Obstet Gynaecol, 1990;97(10):922-9","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"ref12","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","article-title":"Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence","volume":"13","author":"Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E","year":"2012","unstructured":"12. Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E, Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence, Lancet Oncol, 2012;13(3):e103-15","journal-title":"Lancet Oncol"},{"issue":"3","key":"ref13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bpobgyn.2011.12.006","article-title":"Borderline ovarian tumours","volume":"26","author":"Trop\u00e9 CG, Kaern J, Davidson B","year":"2012","unstructured":"13. Trop\u00e9 CG, Kaern J, Davidson B, Borderline ovarian tumours, Best Pract Res Clin Obstet Gynaecol, 2012;26(3):325-36","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"ref14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ygyno.2007.02.030","article-title":"The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review","volume":"105","author":"Vernooij F, Heintz P, Witteveen E, van der Graaf Y","year":"2007","unstructured":"14. Vernooij F, Heintz P, Witteveen E, van der Graaf Y, The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review, Gynecol Oncol, 2007;105(3):801-12","journal-title":"Gynecol Oncol"},{"issue":"3","key":"ref15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/jnci\/djj019","article-title":"Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients","volume":"98","author":"Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A","year":"2006","unstructured":"15. Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients, J Natl Cancer Inst, 2006;98(3):172-80","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"ref16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ygyno.2004.01.029","article-title":"Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach","volume":"94","author":"Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR","year":"2004","unstructured":"16. Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR, Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach, Gynecol Oncol, 2004;94(3):650-4","journal-title":"Gynecol Oncol"},{"issue":"1","key":"ref17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ygyno.2020.04.045","article-title":"Minimally invasive surgery for early-stage ovarian cancer: Association between hospital surgical volume and short-term perioperative outcomes","volume":"158","author":"Matsuo K, Chang EJ, Matsuzaki S, Mandelbaum RS, Matsushima K, Grubbs BH","year":"2020","unstructured":"17. Matsuo K, Chang EJ, Matsuzaki S, Mandelbaum RS, Matsushima K, Grubbs BH, Minimally invasive surgery for early-stage ovarian cancer: Association between hospital surgical volume and short-term perioperative outcomes, Gynecol Oncol, 2020;158(1):59-65","journal-title":"Gynecol Oncol"},{"issue":"7","key":"ref18","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.ejso.2021.01.033","article-title":"Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow up","volume":"47","author":"Gallotta V, Jeong SY, Conte C, Trozzi R, Cappuccio S, Moroni R, Ferrandina G, Scambia G, Kim TJ, Fagotti A","year":"2021","unstructured":"18. Gallotta V, Jeong SY, Conte C, Trozzi R, Cappuccio S, Moroni R, Ferrandina G, Scambia G, Kim TJ, Fagotti A, Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow up, Eur J Surg Oncol, 2021;47(7):1698-1704","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"ref19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ejca.2015.01.004","article-title":"Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk","volume":"51","author":"Vasconcelos I, de Sousa Mendes M","year":"2015","unstructured":"19. Vasconcelos I, de Sousa Mendes M, Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk, Eur J Cancer, 2015;51(5):620-31","journal-title":"Eur J Cancer"},{"issue":"2","key":"ref20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/humupd\/dms047","article-title":"Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options","volume":"19","author":"Dara\u00ef E, Fauvet R, Uzan C, Gouy S, Duvillard P, Morice P","year":"2013","unstructured":"20. Dara\u00ef E, Fauvet R, Uzan C, Gouy S, Duvillard P, Morice P, Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options, Hum Reprod Update, 2013;19(2):151-66","journal-title":"Hum Reprod Update"},{"issue":"8","key":"ref21","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.ejca.2013.01.035","article-title":"Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group","volume":"49","author":"du Bois A, Ewald-Riegler N, de Gregorio N, Reuss A, Mahner S, Fotopoulou C, Arbeitsgmeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group","year":"2013","unstructured":"21. du Bois A, Ewald-Riegler N, de Gregorio N, Reuss A, Mahner S, Fotopoulou C, Arbeitsgmeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group, Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group, Eur J Cancer, 2013;49(8):1905-14","journal-title":"Eur J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejca.2019.01.021","article-title":"Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery","volume":"111","author":"Delle Marchette M, Ceppi L, Andreano A, Bonazzi CM, Buda A, Grassi T, Giuliani D, Sina F, Lamanna M, Bianchi T, Lissoni AA, Landoni F, Valsecchi MG, Fruscio R","year":"2019","unstructured":"22. Delle Marchette M, Ceppi L, Andreano A, Bonazzi CM, Buda A, Grassi T, Giuliani D, Sina F, Lamanna M, Bianchi T, Lissoni AA, Landoni F, Valsecchi MG, Fruscio R, Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery, Eur J Cancer, 2019;11161-68","journal-title":"Eur J Cancer"},{"issue":"10022","key":"ref23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK","year":"2016","unstructured":"23. Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial, Lancet, 2016;387(10022):945-956","journal-title":"Lancet"},{"issue":"10","key":"ref24","doi-asserted-by":"publisher","first-page":"e1003295","DOI":"10.1371\/journal.pmed.1003295","article-title":"The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study","volume":"17","author":"Funston G, Hamilton W, Abel G, Crosbie EJ, Rous B, Walter FM","year":"2020","unstructured":"24. Funston G, Hamilton W, Abel G, Crosbie EJ, Rous B, Walter FM, The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study, PLoS Med, 2020;17(10):e1003295","journal-title":"PLoS Med"},{"issue":"8","key":"ref25","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1245\/s10434-014-3648-z","article-title":"The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer","volume":"21","author":"Lee JY, Kim HS, Chung HH, Kim JW, Park NH, Song YS","year":"2014","unstructured":"25. Lee JY, Kim HS, Chung HH, Kim JW, Park NH, Song YS, The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer, Ann Surg Oncol, 2014;21(8):2762-6","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"ref26","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/jnci\/dji102","article-title":"Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial","volume":"97","author":"Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E","year":"2005","unstructured":"26. Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial, J Natl Cancer Inst, 2005;97(8):560-6","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.105","article-title":"International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma","volume":"95","author":"Trimbos JB, Parmar M, Vergote I, Guthrie D, Bolis G, Colombo N, European Organisation for Research and Treatment of Cancer Collaborators-Adjuvant ChemoTherapy un Ovarian Neoplasm","year":"2003","unstructured":"27. Trimbos JB, Parmar M, Vergote I, Guthrie D, Bolis G, Colombo N, European Organisation for Research and Treatment of Cancer Collaborators-Adjuvant ChemoTherapy un Ovarian Neoplasm, International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma, J Natl Cancer Inst, 2003;95(2):105-12","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"ref28","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJM199004123221501","article-title":"Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials","volume":"322","author":"Young RC, Walton LA, Ellenberg SS, Homesley HD, Wilbanks GD, Decker DG","year":"1990","unstructured":"28. Young RC, Walton LA, Ellenberg SS, Homesley HD, Wilbanks GD, Decker DG, Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials, N Engl J Med, 1990;322(15):1021-7","journal-title":"N Engl J Med"},{"issue":"32","key":"ref29","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1200\/JCO.2009.22.3248","article-title":"Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2","volume":"27","author":"Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS","year":"2009","unstructured":"29. Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2, J Clin Oncol, 2009;27(32):5331-6","journal-title":"J Clin Oncol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial","volume":"95","author":"Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, EORTC-ACTION collaborators","year":"2003","unstructured":"30. Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, EORTC-ACTION collaborators, European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial, J Natl Cancer Inst, 2003;95(2):113-25","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"ref31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/sj.bjc.6603323","article-title":"Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis","volume":"95","author":"Maggioni A, Benedetti Panici P, Dell'Anna T, Landoni F, Lissoni A","year":"2006","unstructured":"31. Maggioni A, Benedetti Panici P, Dell'Anna T, Landoni F, Lissoni A, Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis, Br J Cancer, 2006;95(6):699-704","journal-title":"Br J Cancer"},{"issue":"3","key":"ref32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman RJ, Shih IeM","year":"2010","unstructured":"32. Kurman RJ, Shih IeM, The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory, Am J Surg Pathol, 2010;34(3):433-43","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ygyno.2009.03.001","article-title":"Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant","volume":"114","author":"Gershenson DM, Sun CC, Bodurka D, Coleman RL, Lu KH, Sood AK, Deavers M, Malpica AL, Kavanagh JJ","year":"2009","unstructured":"33. Gershenson DM, Sun CC, Bodurka D, Coleman RL, Lu KH, Sood AK, Deavers M, Malpica AL, Kavanagh JJ, Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant, Gynecol Oncol, 2009;114(1):48-52","journal-title":"Gynecol Oncol"},{"issue":"1","key":"ref34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/gyno.2002.6710","article-title":"Long-term survival and patterns of care in women with ovarian tumours of low malignant potential","volume":"86","author":"Trimble CL, Kosary C, Trimble EL","year":"2002","unstructured":"34. Trimble CL, Kosary C, Trimble EL, Long-term survival and patterns of care in women with ovarian tumours of low malignant potential, Gynecol Oncol, 2002;86(1):34-7","journal-title":"Gynecol Oncol"},{"issue":"11","key":"ref35","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1097\/01.pas.0000213306.07194.01","article-title":"The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent","volume":"30","author":"Silva EG, Gershenson DM, Malpica A, Deavers M","year":"2006","unstructured":"35. Silva EG, Gershenson DM, Malpica A, Deavers M, The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent, Am J Surg Pathol, 2006;30(11):1367-71","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"ref36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","article-title":"Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies","volume":"243","author":"Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP","year":"2006","unstructured":"36. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP, Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies, Ann Surg, 2006;243(2):212-22","journal-title":"Ann Surg"},{"issue":"3","key":"ref37","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel E","year":"2010","unstructured":"37. Lengyel E, Ovarian cancer development and metastasis, Am J Pathol, 2010;177(3):1053-64","journal-title":"Am J Pathol"},{"issue":"15","key":"ref38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H","year":"1983","unstructured":"38. Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer, N Engl J Med, 1983;309(15):883-7","journal-title":"N Engl J Med"},{"issue":"1","key":"ref39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1525-1438.2006.00777.x","article-title":"Ascites and epithelial ovarian cancers: a reappraisal with respect to different aspects","volume":"17","author":"Ayhan A, Gultekin M, Taskiran C, Dursun P, Firat P, Bozdag G","year":"2007","unstructured":"39. Ayhan A, Gultekin M, Taskiran C, Dursun P, Firat P, Bozdag G, Ascites and epithelial ovarian cancers: a reappraisal with respect to different aspects, Int J Gynecol Cancer, 2007;17(1):68-75","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"ref40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ","year":"2009","unstructured":"40. Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass, Gynecol Oncol, 2009;112(1):40-6","journal-title":"Gynecol Oncol"},{"issue":"8","key":"ref41","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1471-0528.1996.tb09882.x","article-title":"Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses","volume":"103","author":"Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T","year":"1996","unstructured":"41. Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses, Br J Obstet Gynaecol, 1996;103(8):826-31","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"ref42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ygyno.2012.07.106","article-title":"Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass","volume":"127","author":"Karlsen MA, Sandhu N, H\u00f8gdall C, Christensen IJ, Nedergaard L, Lundvall L","year":"2012","unstructured":"42. Karlsen MA, Sandhu N, H\u00f8gdall C, Christensen IJ, Nedergaard L, Lundvall L, Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass, Gynecol Oncol, 2012;127(2):379-83","journal-title":"Gynecol Oncol"},{"issue":"1","key":"ref43","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW","year":"2015","unstructured":"43. Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration, Ann Intern Med, 2015;162(1):W1-73","journal-title":"Ann Intern Med"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-9-2025\/original-article-issue-9-2025\/staging-discordance-in-apparent-early-stage-ovarian-neoplasms-prevalence-prognosis-and-practical-risk-stratification\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:05:48Z","timestamp":1763388348000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-9-2025\/original-article-issue-9-2025\/staging-discordance-in-apparent-early-stage-ovarian-neoplasms-prevalence-prognosis-and-practical-risk-stratification\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["JMedLife-18-878"],"URL":"https:\/\/doi.org\/10.25122\/jml-2025-0131","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}